MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
105 hedge funds and large institutions have $592M invested in Marinus Pharmaceuticals, Inc in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 33 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 33
1% more funds holding
Funds holding: 104 → 105 (+1)
Holders
105
Holding in Top 10
3
Calls
$12.9M
Puts
$826K
Top Buyers
| 1 | +$12.2M | |
| 2 | +$8.56M | |
| 3 | +$6.79M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$6.01M |
| 5 |
BlackRock
New York
|
+$4.93M |
Top Sellers
| 1 | -$6.21M | |
| 2 | -$3.51M | |
| 3 | -$3.18M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.61M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.04M |